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BACKGROUND: Metabolic syndrome (MetS)is increasingly 
becoming a challenging public health issue in Palestine. The 
current burden of MetS in the country is unknown. There has been 
limited research on the prevalence of MetS. This meta-analysis is 
the first to estimate the population prevalence of MetS and its 
related factors among adults in Palestine. 
METHODS: A PRISMA systematic search appraisal and meta-
analysis were conducted. A systematic literature search of PubMed, 
Scopus and Google Scholar was conducted in December 2014 up to 
February 2015. Generic, methodological and statistical data was 
extracted from the eligible studies which reported MetS prevalence. 
A random effect meta-analysis was conducted on crude MetS 
prevalence rates. Heterogeneity was assessed by Cochran’s Q and 
I
2 
tests. Subgroup analyses were also performed according to the 
predefined criteria.  
RESULTS: The literature search yielded a total of 49 studies. Eight 
papers were included in the final analysis with sample size ranging 
163 to 992. In addition, 2937 cases with MetS among people aged 
15 years or more were estimated in Palestine between 2001 and 
2014. There was high heterogeneity among studies (I
2
 = 95.8% 
p<0.001). The prevalence of MetS was 37.0% among adult 
Palestinians population ranging from 17 to 59.5%. Subgroup 
analysis did not show source of heterogeneity based on subject's 
health status and MetS criteria. 
CONCLUSION: Our meta-analysis clearly demonstrates that MetS 
is highly prevalent (37.0%) among Palestinian adults. The high 
prevalence of MetS in Palestine should be seriously considered and 
planners should take steps to reduce it.  
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INTRODUCTION   
 
It is observable that cardiovascular disease (CVD) 
and associated premature mortality have become a 
major concern in adult Palestinian population. In 
addition, people with MetS carry a much higher 
risk of CVD. MetS is a cluster of the most 
dangerous heart attack risk factors: diabetes, 
raised fasting plasma glucose, abdominal obesity, 
high cholesterol and high blood pressure (1-3). 
Based on reports, around 20-25 percent of the 
world’s adult population have the MetS, and 
mortality rate among these people is twice as 
likely from heart attack, and three times as likely 
from stroke compared with people without MetS 
(3). In addition, the risk of developing type 2 
diabetes among people with MetS is a fivefold (4). 
The clustering of CVD risk factors that typifies 
MetS is now considered to be the driving force for 
a new CVD epidemic (5). A number of expert 
groups have developed clinical criteria for the 
MetS. The most widely accepted of these were 
produced by the World Health Organization 
(WHO), the European Group for the Study of 
Insulin Resistance, the National Cholesterol 
Education Program-Third Adult Treatment Panel 
(NCEP/ATP III) and the International Diabetes 
Federation definition (IDF) (4-7).  
The underlying cause of the MetS continues 
to challenge the experts but both insulin resistance 
and central obesity are considered the main causes 
(8). Genetic and environmental factors such as 
sedentary lifestyle, unhealthy dietary habits and 
high rates of cigarette smoking contribute to MetS 
development (9). In the general population, 
genetic and geographical environment differences 
might partially be responsible for the prevalence 
rates of MetS alter in different countries (9-12). 
Despite the importance of MetS in the context of 
metabolic and CVD in Palestine, few studies have 
described the prevalence of MetS and its related 
factors, hence restricting the quality of 
information available on the magnitude of this 
problem in the country. Gathering reliable 
information about the prevalence of MetS and its 
related factors in various populations can be very 
effective in the planning and use of preventive 
strategies for such diseases. Moreover, the current 
burden of MetS in Palestine is unknown. 
Therefore, to help provide a clearer picture of the 
current situation in Palestine, we conducted a 
meta-analysis with an objective to clarify the 
prevalence rate of MetS and its related factors 
among the adult Palestinian population. The 
findings of this study will give baseline 
information about the prevalence of MetS and its 
related factors among the adult Palestinian 
population. 
METHODS 
Literature searches of PubMed, Scopus and 
Google scholar for publications in English were 
conducted in December 2014 up to February 2015 
for all published data related to MetS in Palestine. 
Unpublished studies were not retrieved. To 
maximize the possibility of including all relevant 
studies, the following search strategy was used: 
(("Metabolic syndrome" OR "Syndrome of 
Affluence" OR "Plurimetabolic syndrome" OR 
"Syndrome X" OR "Metabolic syndrome X" OR 
"Reaven syndrome" OR "Insulin resistance 
syndrome" OR "Insulin 
resistance/hyperinsulinemia syndrome" OR 
"Atherothrombogenic syndrome" OR "Metabolic 
cardiovascular syndrome" OR "Syndrome X plus" 
"Deadly quartet" OR "Cardiovascular and 
metabolic syndrome" OR "Dysmetabolic 
syndrome X" OR "MetSyn" OR "Wohlstands 
syndrome" OR "Android obesity syndrome" OR 
"Dysmetabolic syndrome" OR 
"Hypertriglyceridemic syndrome" OR "Obesity 
syndrome" OR "Obesity dyslipidemia syndrome" 
OR "Hypertriglyceridemic waist") AND (Palestine 
OR West Bank OR Jenin OR Tubas OR Tukarml 
OR Nablus OR Qalqilya OR Salfit OR Ramallah 
OR Jericho OR Jerusalem OR Bethlehem OR 
Hebron OR Gaza Strip OR North Gaza OR Gaza 
Governorate OR Deir Al Balah OR Khan Yunis 
OR Rafah)). Thirteen, thirty-three and six articles 
were found in the databases PubMed, Google 
scholar and Scopus, respectively. To satisfy the 
analysis requirements and reduce selection 
deviation, the selected studies were required to 
meet the following criteria: 1) a population-based 
study conducted in Palestine; 2) studies with 
random sampling and sufficient information of 
sample size, 3) crude prevalence of MetS, 4) 
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participants aged of 15 years or above and 5) use 
of  MetS diagnostic criteria. The total number of 
articles found was 49. According to the PRISMA 
flow chart, ten of the articles after duplicates were 
removed, twenty-one of articles were excluded 
because their title and abstract were not related to 
prevalence of MetS and not compatible with the 
study objective while eighteen of full text articles 
were assessed for eligibility. Only eight papers 
were included in the final analysis. After 
determining the qualified papers, data were 
extracted according to a standard protocol. To 
improve accuracy and critical appraisal, data 
extraction was conducted by two independent 
researchers, and disputes between researchers 
were resolved through consensus. Generic, 
methodological and statistical information was 
extracted from the eligible studies which reported 
MetS prevalence including age, sex, geographical 
location, year of publication, sample size and 
prevalence of MetS. A random effect meta-
analysis was conducted on crude MetS prevalence 
rates, and heterogeneity was assessed by 
Cochran’s Q and I
2 
tests(13,14). The presence of 
heterogeneity was determined by the chi
2
 test with 
a significance level of <0.1 combined with an I
2
 
statistic for estimates of inconsistency within the 
meta-analyses. The I
2
 statistics estimates the 
percent of observed between-study variability due 
to heterogeneity rather than chance; ranges from 0 
to 100 percent. For this review, we determined 
that I
2
 values above 75% were indicative of 
significant heterogeneity warranting analysis with 
a random effect model as opposed to the fixed 
effect model to adjust for the observed variability 
between studies. Subgroup analyses were also 
performed according to the predefined criteria 
including health status, age and criteria used for 
MetS. Egger test was conducted to examine 
potential publication bias. 
 
RESULTS 
Flow chart of the study is shown in Figure 1. A 
total of 49 articles were found in the initial search 
and after removing duplicates and screening, eight 
articles were included in the study. Included 
studies were from 2001 to 2013 in West Bank, 
Jerusalem and Gaza Strip. The total sample size of 
the eight included studies was 2937 subjects 
(ranging 163-992). The age range of the 
participants was 16 to 65, and the criteria used to 
assess MetS in these studies were NCEP/ATP III, 
WHO and IDF criteria; NCEP/ATP III was the 
most often used. Characteristics and data of the 
articles are presented in Table 1. The prevalence 
of MetS by random effect was 37.0% (955 
CI=0.25%-0.45%) (Figure 2). The heterogeneity 
was I
2
 = 95.8%, p = 0.000). The subgroup analysis 
by subject health status and MetS criteria (IDF vs. 
NCEP/ATP III) did not remove heterogeneity 
among studies. There was no evidence of 
publication bias (Egger’s test β0: 11.8; p=0.07). 
With respect to factors associated with MetS, our 
results showed that the prevalence of MetS varied 
depending on the definition used for diagnosing 
MetS. IDF’s definition provided significantly 
higher prevalence (mean = 43.7%) of MetS in 
Palestinian adults compared to NCEP/ATP III’s 
definition (mean = 37.27%) and WHO’s definition 
(mean = 17%). In addition, the MetS is more 
prevalent in women (mean = 42.55%) than men 
(mean = 35.41%). Also, the prevalence of overall 
obesity was 51.95% and 37.8% in women and 
men respectively. Furthermore, in our meta-
analysis, the studies which used IDF criteria for 
MetS showed that the prevalence of MetS 
increased by age. Moreover, our results showed 
that the prevalence of MetS appeared to be high 
among unhealthy participants (studies were done 
on patients) (mean = 48.67%) compared to healthy 
participants (mean = 25.62%) in all included 
studies. Finally, our results showed that the 
prevalence of MetS in Palestinian's adults residing 
in northern Palestine (West Bank governorates 
(mean = 38.05%)) was higher than those residing 
in southern Palestine (Gaza Strip governorates 
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Figure 1: Results of the systematic literature search 
 
 
Figure 2: The prevalence of MetS. 
49 of records identified through 
Database searching 
10 of records after duplicates removed 
39 of records screened 
18 of full text articles assessed for 
eligibility 
21 of records were excluded; reasons: 
Title and abstract were not related to 
prevalence of metabolic syndrome. 
Not compatible with study objective. 
Data not in usable format. 
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To the author's knowledge, the present meta-analysis 
is the first to demonstrate the prevalence of MetS in 
Palestinian's adults. In this meta-analysis, after 
random effect model meta-analysis, results showed 
that the prevalence of MetS in Palestinian adults is 
about 37.0%. There was a considerable 
heterogeneity among the included studies. In order to 
reduce the heterogeneity, we divided the studies into 
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subgroups by subject's health status and MetS 
criteria to achieve homogeneity. Nonetheless, 
homogeneity was not achieved. MetS is a global 
problem, approximately around a quarter of the 
world׳s adult population has MetS (15), and one 
fourth of the European adult population was 
estimated to have MetS (15). In the Middle East, the 
MetS affects about one in four people and its 
prevalence increases with age (16). In our meta-
analysis, the prevalence of MetS was relatively high 
compared to US (17), Europe (18), China (19) and 
Iran (20) and varied depending on the definition used 
for diagnosing MetS. IDF’s definition provided 
significantly higher prevalence (mean = 43.7%) of 
MetS in Palestinian adults compared to NCEP/ATP 
III’s definition (mean = 37.27%) and WHO’s 
definition (mean = 17%) (10-12, 21-24). The high 
prevalence of MetS may be related in part to 
differences in the definitions used and the 
populations studied. Therefore, the use of a single 
criterion would identify the prevalence of MetS with 
greater sensitivity. Other factors that could explain 
the difference include different lifestyles and 
different socioeconomic status. According to 
previous studies in Jordan (25), Turkey (26), Tunisia 
(27), Saudi (28), and Iran (20), the prevalences of 
MetS were 36.3%, 33.9%, 24.3%, 21%, and 34.7% 
respectively. The prevalence of MetS in those 
studies is approximately the same as what was found 
in this review. Furthermore, the prevalence of MetS 
was higher among females in these countries (20, 25-
28). Our results showed that the MetS is more 
prevalent among women (mean = 42.55%) than 
among men (mean = 35.41%) which is a common 
finding in previous studies (29-32). In Arab 
countries, women had a higher prevalence of MetS 
compared to men (33-35). This also fits with the 
Palestinians and is related to the higher incidence of 
obesity among women (36-38). 
In our meta-analysis, the prevalence of overall 
obesity was 51.95% and 37.8% in women and men 
respectively. Multiple pregnancies, high 
unemployment, over-eating, little physical activity 
and a loss of interest in body shape after marriage 
and childbirth (which is related to cultural and social 
restrictions) are associated with increased prevalence 
of obesity in women (36). Age is another important 
and strongly associated risk factor for MetS (39). In 
our meta-analysis, the studies which used IDF’s 
criteria for MetS showed that the prevalence of MetS 
increased by age (11, 12, 23). The positive 
associations of aging with hypertension, diabetes and 
obesity were illustrated among Palestinian adult 
population (21). Moreover, continuously increasing 
weight in women with age could in part be an effect 
of premenopausal and menopausal disturbances 
which was found to be associated with visceral fat 
accumulation and acute increase of insulin resistance 
(40). In addition, our results showed that the 
prevalence of MetS appeared to be high among 
unhealthy participants (studies were done on 
patients) (mean = 48.67%) compared to healthy 
participants (mean = 25.62%) in all included studies. 
Furthermore, our results showed that the prevalence 
of MetS in Palestinian adults residing in northern 
Palestine (West Bank governorates (mean = 
38.05%)) was higher than those residing in southern 
Palestine (Gaza Strip governorates (mean = 
36.25%)) indicated that the prevalence of MetS may 
be affected by different geographical area.  
One limitation of this meta-analysis was the 
heterogeneity in the criteria used to define MetS 
among studies. The strength of this study is that it is 
the first study which shows the prevalence of MetS 
in Palestinian adults. The present meta-analysis 
study may provide a baseline data on the prevalence 
of MetS in Palestinian's adults and can guide other 
researchers to design new studies. 
In conclusion, our meta-analysis clearly shows 
that MetS is highly prevalent (37.0%) among 
Palestinian adults. The high prevalence of MetS in 
Palestine should be seriously considered by 
stakeholders to reduce it. Future prospective studies 
investigating the prevalence of MetS and its 
components among Palestinian population would 
benefit from using a single, universally accepted 
diagnostic tool for MetS. This would enable 
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